MRL Ventures Fund Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
4
- Investments
-
59
- Portfolio
-
19
- Exits
-
19
MRL Ventures Fund General Information
Company Description
Founded in 2015, MRL Ventures Fund is the corporate venture capital arm of Merck & Co. based in Cambridge, Massachusetts. The firm prefers to invest in seed and early-stage therapeutics companies.
Business Details
Website
www.mrlv.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 320 Bent Street
- 4th Floor
- Cambridge, MA 02141
- United States
MRL Ventures Fund Investments (59)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| VectorY Therapeutics | 11-Nov-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| InduPro | 12-Aug-2026 | Drug Discovery | Pre-Clinical Trials | |||
| Ray Therapeutics | 21-Apr-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| PAQ Therapeutics | 22-Jan-2026 | Drug Discovery | Generating Revenue | |||
| Myoventive | 01-Jun-2025 | Biotechnology | Startup | |||
| Therini Bio | 14-May-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Topo Therapeutics | 17-Dec-2024 | Drug Discovery | Startup | |||
| Axonis Therapeutics | 30-Oct-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| atbtherapeutics | 01-Oct-2024 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| Aktis Oncology | 20-Sep-2024 | Early Stage VC | Drug Discovery | Generating Revenue |
MRL Ventures Fund Exits (19)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Aktis Oncology | 09-Jan-2026 | IPO | |
| EyeBio | 10-Jul-2024 | ||
| Caraway Therapeutics | 20-Nov-2023 | ||
| Entrada Therapeutics | 02-Nov-2021 | ||
| Xilio Therapeutics | 22-Oct-2021 | ||
| Invivyd | 06-Aug-2021 | ||
| Imago BioSciences | 09-Jul-2021 | ||
| Tidal Therapeutics | 09-Apr-2021 | ||
| Lava Therapeutics | 25-Mar-2021 | IPO | |
| Kymera Therapeutics | 21-Aug-2020 | IPO |
MRL Ventures Fund Investments by Industry, Year, and Region
MRL Ventures Fund Co-Investors (119)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alexandria Venture Investments | 3 |
|
|
||
| Eli Lilly and Company Foundation |
|
|
|||
| Lilly USA |
|
|
|||
| venBio |
|
|
|||
| Invus (Private Equity) |
|
|
MRL Ventures Fund FAQs
-
What is MRL Ventures Fund?
Founded in 2015, MRL Ventures Fund is the corporate venture capital arm of Merck & Co.
-
When was MRL Ventures Fund founded?
MRL Ventures Fund was founded in 2015.
-
Where is MRL Ventures Fund headquartered?
MRL Ventures Fund is headquartered in Cambridge, MA.
-
What is MRL Ventures Fund's total asset value?
MRL Ventures Fund has around in total assets under management.
-
How many investments has MRL Ventures Fund made?
MRL Ventures Fund has made 59 investments.
-
What has MRL Ventures Fund invested in?
MRL Ventures Fund has made numerous investments in companies like VectorY Therapeutics, InduPro, and Ray Therapeutics within the Drug Discovery industry.
-
What has MRL Ventures Fund invested in recently?
MRL Ventures Fund's latest investment was on 11-Nov-2026 in VectorY Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process